Endocrine, metabolic & immune disorders drug targets
Association of Fibrinogen-Like Protein 1 with Metabolic Disorders and Pregnancy Outcomes: A Case-Control Study.
Li Jiang, Shan Zhang, Zhibiao Jiang, Xuemei Yu, Hua Jin, Peihong Chen
Published: 202610.2174/0118715303416614251106110927
Abstract
INTRODUCTION: This study aimed to assess the relationship between fibrinogen-like protein 1 (FGL1) and adverse pregnancy outcomes (APOs) as well as metabolic disorders during pregnancy. METHODS: The pregnant women from 24 to 28 weeks of gestation wer…
Preview only. Read the full abstract at the source